Related Experiment Videos
Endoscopic third ventriculostomy in obstructed hydrocephalus.
Neurology India
|July 17, 2003
Summary
Endoscopic Third Ventriculostomy (ETV) offers an alternative to Ventriculoperitoneal (VP) Shunt for obstructive hydrocephalus. ETV showed significant clinical and radiological improvement, especially in older patients.
Area of Science:
- Neurosurgery
- Pediatric Neurosurgery
- Neurology
Background:
- Obstructive hydrocephalus is a condition requiring intervention to manage cerebrospinal fluid (CSF) pathway obstruction.
- Ventriculoperitoneal (VP) shunt has been a traditional treatment, but carries risks and complications.
- Endoscopic Third Ventriculostomy (ETV) presents a less invasive alternative for specific types of hydrocephalus.
Purpose of the Study:
- To evaluate the efficacy and safety of Endoscopic Third Ventriculostomy (ETV) in patients with obstructive hydrocephalus.
- To compare ETV outcomes in different age groups: infants/young children versus older children/adults.
- To assess ETV as an alternative to VP shunt for managing CSF pathway obstruction.
Main Methods:
- Forty-three ETV procedures were performed in 46 patients diagnosed with obstructive hydrocephalus.
- Patients were divided into two groups: Group 1 (29 children < 2 years) and Group 2 (17 patients > 2 years, adolescents, adults).
- Clinical and radiological outcomes were assessed for both groups to determine treatment success and complications.
Main Results:
- Group 1 (< 2 years) achieved 70% clinical and 63% radiological improvement.
- Group 2 (> 2 years) demonstrated higher success rates with 100% clinical and 73% radiological improvement.
- ETV failed in eight patients, who subsequently benefited from VP shunt; one unrelated postoperative death occurred.
Conclusions:
- ETV is a viable and effective alternative to VP shunt for obstructive hydrocephalus, particularly in older pediatric and adult populations.
- While ETV shows promising results, VP shunt remains a necessary option for cases where ETV is unsuccessful.
- The study highlights ETV's potential to improve CSF flow and reduce reliance on shunts in managing hydrocephalus.